2012
DOI: 10.1111/j.1742-4658.2012.08498.x
|View full text |Cite
|
Sign up to set email alerts
|

Epigallocatechin‐3‐gallate and penta‐O‐galloyl‐β‐d‐glucose inhibit protein phosphatase‐1

Abstract: Protein phosphatase-1 (PP1) and protein phosphatase-2A (PP2A) are responsible for the dephosphorylation of the majority of phosphoserine ⁄ threonine residues in cells. In this study, we show that (-)-epigallocatechin-3-gallate (EGCG) and 1,2,3,4,6-penta-O-galloyl-b-D-glucose (PGG), polyphenolic constituents of green tea and tannins, inhibit the activity of the PP1 recombinant d-isoform of the PP1 catalytic subunit and the native PP1 catalytic subunit (PP1c) with IC 50 values of 0.47-1.35 lM and 0.26-0.4 lM, re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
32
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(36 citation statements)
references
References 50 publications
(91 reference statements)
4
32
0
Order By: Relevance
“…Of note EGCG, possibly through its galloyl group, inhibits the activity of PP1 at physiological achievable concentrations. Comparative docking assay shows that EGCG binds to PP2A in a similar manner, but in a distinct domain [53,54]. This inhibitory effect of the EGCG on phosphatases might be invoked to explain the higher level of PLB phosphorylation in GTE cardiomyocytes.…”
Section: Cellular Physiology and Biochemistrymentioning
confidence: 97%
“…Of note EGCG, possibly through its galloyl group, inhibits the activity of PP1 at physiological achievable concentrations. Comparative docking assay shows that EGCG binds to PP2A in a similar manner, but in a distinct domain [53,54]. This inhibitory effect of the EGCG on phosphatases might be invoked to explain the higher level of PLB phosphorylation in GTE cardiomyocytes.…”
Section: Cellular Physiology and Biochemistrymentioning
confidence: 97%
“…This liposome encapsulation method has been utilized for epigallocatechin-3-gallate (EGCG) 201 (a polyphenolic compound similar to PGG 85 ) and IC 50 of PGG, which is almost half that of EGCG. 16 This technique can be extended for improvement of PGG bioavailability.…”
Section: Current Issues With Pgg Administrationmentioning
confidence: 99%
“…In our previous work we showed that EGCG interacted with and inhibited PP1c activity at micromolar concentrations in in vitro phosphatase assays and binding of EGCG to the hydrophobic groove of the PP1c substrate binding region was also established42. However, only moderate extent of phosphatase inhibition occurred when intact cells were incubated with relatively high EGCG concentration (100–500 μM) and it was presumably due to low extent of EGCG permeation through the cell membranes43.…”
Section: Discussionmentioning
confidence: 97%